Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Regulatory Actions
Independent Forecasts and Competitive Intelligence on Saudi Arabia's Pharmaceuticals & Healthcare Industry
July 10th, 2007
Research and Markets has announced the addition of "Saudi Arabia Pharmaceuticals & Healthcare Report Q4 2006" to their offering. The Saudi Arabian pharmaceutical market is the largest in the Arabian Gulf region and was worth an estimated US$1.14bn in 2005. However, it is cautioned that growth will be sluggish despite favourable economic conditions in the country. This is primarily due to tight price controls. Products can be sold in the country only after the Ministry of Health (MoH) has approved their prices. US drug industry association PhRMA says that these controls act as a considerable barrier to investment. The...
Source: Drug Law Weekly (2007-07-10)
|
